Associate Director, Histocompatibility Laboratory
Mayo Clinic Arizona
Cave Creek, AZ
Ruby J. Siegel, PhD, F(ACHI), HCLD(ABB) joined the Department of Laboratory Medicine and Pathology at Mayo Clinic in Phoenix, Arizona, as an Associate Director of the histocompatibility laboratory in February 2024. She has considerable technical and operational experience in HLA. She worked as an HLA laboratory specialist for 16 years at the Inland Northwest Blood Center (now Vitalant) in Spokane, WA, during which she obtained Certified Histocompatibility Technologist (CHT) and Certified Histocompatibility Specialist (CHS) certifications through the American College of Histocompatibility and Immunogenetics (ACHI). Then she was hired as the General Supervisor of Serology and Processing in the HLA Laboratory at Stanford Blood Center in Palo Alto, CA. Ultimately, she decided to pursue a PhD so that she could become an HLA Laboratory Director. She was accepted into the Pharmaceutical Science and Molecular Medicine program at the Washington State University in Spokane, WA. After obtaining her PhD she entered the Director-in-Training Fellowship in the Transplant Immunology Laboratory at Northwestern University in Chicago, IL. Ruby completed her fellowship in December 2023 and achieved board certification in 2024. Her research interests include drug targets to control inflammation and novel immunosuppressive therapies to facilitate transplant for highly sensitized patients.
Workshop 3: B cells and Beyond: The players of antibody mediated rejection
Tuesday, October 7, 2025
4:45 PM - 6:15 PM US EDT
Practical Applications & International Scholar Session
Thursday, October 9, 2025
2:45 PM - 4:15 PM US EDT
Thursday, October 9, 2025
3:45 PM - 4:00 PM US EDT